BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1733800)

  • 1. HLA and insulin-dependent diabetes. A protective perspective.
    Sheehy MJ
    Diabetes; 1992 Feb; 41(2):123-9. PubMed ID: 1733800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.
    Baisch JM; Weeks T; Giles R; Hoover M; Stastny P; Capra JD
    N Engl J Med; 1990 Jun; 322(26):1836-41. PubMed ID: 2348836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA haplotype sharing and proband genotype in IDDM.
    Rotter JI; Vadheim CM; Petersen GM; Cantor RM; Riley WJ; Maclaren NK
    Genet Epidemiol Suppl; 1986; 1():347-52. PubMed ID: 3569864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
    Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
    Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia.
    La Nasa G; Carcassi C; Cirillo R; Mulargia M; Leone AL; Vacca A; Pizzati A; Boero R; Arras M; Porcella R
    Dis Markers; 1990; 8(6):333-40. PubMed ID: 2101347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.
    Khalil I; Deschamps I; Lepage V; al-Daccak R; Degos L; Hors J
    Diabetes; 1992 Mar; 41(3):378-84. PubMed ID: 1551498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unified hypothesis for the complex genetics of HLA associations with IDDM.
    Nepom GT
    Diabetes; 1990 Oct; 39(10):1153-7. PubMed ID: 2210067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles.
    Penny MA; Jenkins D; Mijovic CH; Jacobs KH; Cavan DA; Yeung VT; Cockram CS; Hawkins BR; Fletcher JA; Barnett AH
    Diabetes; 1992 Aug; 41(8):914-9. PubMed ID: 1628765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles.
    Balducci-Silano PL; Layrisse ZE
    J Autoimmun; 1995 Jun; 8(3):425-37. PubMed ID: 7576003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential transmission of diabetic alleles within the HLA gene complex.
    Vadheim CM; Rotter JI; Maclaren NK; Riley WJ; Anderson CE
    N Engl J Med; 1986 Nov; 315(21):1314-8. PubMed ID: 3490623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland.
    Reijonen H; Ilonen J; Knip M; Akerblom HK
    Diabetes; 1991 Dec; 40(12):1640-4. PubMed ID: 1756904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.
    Sterkers G; Zeliszewski D; Chaussée AM; Deschamps I; Font MP; Freidel C; Hors J; Betuel H; Dausset J; Levy JP
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6473-7. PubMed ID: 2901099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance.
    MacDonald MJ; Gottschall J; Hunter JB; Winter KL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7049-53. PubMed ID: 3489237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland.
    Langholz B; Tuomilehto-Wolf E; Thomas D; Pitkäniemi J; Tuomilehto J
    Genet Epidemiol; 1995; 12(5):441-53. PubMed ID: 8557177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of dq.
    Harfouch-Hammoud E; Timsit J; Boitard C; Bach JF; Caillat-Zucman S
    J Autoimmun; 1996 Jun; 9(3):411-4. PubMed ID: 8816979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.